C4 Therapeutics surges after monotherapy shows signs of anti-myeloma activity HIGHER
- C4 Therapeutics (CCCC) up 17.1% after announcing that its CFT7455 monotherapy shows signs of anti-myeloma activity
- Blend Labs (BLND) up 5.7% after Keefe Bruyette raised its price target on the stock
- NuZee (NUZE) up 4.3% after naming Randell Weaver president and COO
- SLM (SLM) up 3.8% after saying it sees the capacity to return over $2B to shareholders over the next five years
- DoubleVerify (DV) up 3.1% after Morgan Stanley initiated coverage of the stock with an Overweight rating
LOWER
- Qiagen (QGEN) down 3% after Wolfe initiated coverage of the stock with a Peer Perform rating
Symbols:
CCCC BLND NUZE SLM DV QGEN Keywords: fly intel, wall street, afterhours, movers, top stories, stocks